Apsis Aerocom IPO Review — Should You Apply?
Moderate Sentiment
Reasonable grey market premium and moderate subscription suggest balanced market interest.
Detailed Investment Analysis
Apsis Aerocom's IPO presents a valuation that warrants careful consideration. The P/E ratio of 13.8x, derived from an EPS of ₹7.54 and a price band of ₹104, appears reasonable, especially when contrasted with the company's exceptional profitability metrics. While a direct industry comparison for this niche SME is challenging, a P/E in this range often suggests that the market is pricing in growth expectations for companies with strong financial performance. The Net Asset Value (NAV) of ₹12.01, coupled with the issue price, indicates a premium valuation, but this is often justified by high return ratios. Financially, Apsis Aerocom exhibits a robust picture. Its revenue of ₹13.65 crore is accompanied by a PAT of ₹3.12 crore, translating to a healthy PAT margin. The impressive EBITDA margin of 49.78% is a significant strength, indicating strong operational efficiency and cost management. Furthermore, the RONW of 62.82% and ROCE of 65.76% are exceptionally high, signaling that the company effectively utilizes its equity and capital to generate profits. These metrics suggest a business of high quality with significant leverage on its asset base. Based on the provided financials, the company shows clear signs of growth and profitability. The strong return ratios suggest efficient capital deployment and a healthy business model that is capable of generating substantial returns. The fresh issue component of the IPO, totaling ₹35.77 crore, is earmarked for growth capital, which is a positive sign for future expansion. However, investors must also consider the inherent risks associated with SME IPOs. The limited track record, compared to larger listed entities, can introduce unforeseen volatility. Sector-specific risks within aerospace and defence, such as regulatory changes or geopolitical shifts, could impact demand for Apsis Aerocom's products. While the valuation appears reasonable on a P/E basis, the premium to NAV suggests that future growth needs to be consistently delivered to justify the current pricing. Subscription sentiment, if available, would offer further insights into market appetite. High interest from retail and high-net-worth individuals could indicate confidence in the company's prospects and management. Investors should consult a SEBI-registered financial advisor before making investment decisions.
Strengths
- The company boasts exceptionally high return ratios, with RONW at 62.82% and ROCE at 65.76%. These strong figures indicate efficient management of shareholder funds and capital employed, suggesting a profitable and well-run business.
- Apsis Aerocom demonstrates a very strong EBITDA margin of 49.78%. This high margin points to excellent operational efficiency and pricing power within its niche market, suggesting robust control over costs and a potentially superior competitive advantage.
- The IPO is structured as a 100% fresh issue, raising ₹35.77 crore for the company. This signifies that the capital raised will be deployed for business expansion and growth initiatives, rather than for promoters to exit their stake.
- The company operates in the aerospace and defence sector, which is a strategically important and technologically driven industry. This sector often benefits from government support and long-term growth potential, providing a favourable environment for expansion.
- With an EPS of ₹7.54 and a price band of ₹104, the P/E ratio is 13.8x, which appears reasonable for a company exhibiting such strong profitability and return metrics, especially within the SME segment.
Risks & Concerns
- As an SME IPO, Apsis Aerocom may have a more limited operating history and financial track record compared to larger listed companies. This can introduce higher volatility and uncertainty for investors.
- The company is valued at a premium relative to its Net Asset Value (NAV) of ₹12.01, with an issue price of ₹104. This suggests that future growth must be substantial and consistent to justify the current valuation and provide returns.
- The aerospace and defence sector, while offering growth potential, is also subject to significant external factors such as government policies, defence spending cycles, and geopolitical developments. Any adverse changes in these areas could impact the company's performance.
- While the P/E ratio of 13.8x appears reasonable, it is crucial to ensure that the company can sustain its high profitability and growth trajectory to meet market expectations. Any faltering in performance could lead to a valuation re-rating.
- The lot size of 1200 shares requires a minimum investment of ₹124,800, which is a substantial amount for retail investors. This higher entry point might limit participation from smaller investors.
Want Full IPO Data?
This review focuses on analysis. For complete IPO details — GMP history, subscription day-wise, financial tables, allocation breakdown, and registrar/lead manager info — visit the full data page.
View Apsis Aerocom IPO Full Details →Frequently Asked Questions
What is Apsis Aerocom IPO price band and lot size?
The Apsis Aerocom IPO has a fixed price band of ₹104 per share, with a face value of ₹10 per share. The lot size for this IPO is 1200 shares, meaning the minimum investment for a retail investor is ₹124,800 (1200 shares x ₹104 per share). Retail investors can apply for multiple lots, subject to application limits.
Is Apsis Aerocom IPO worth investing in?
Apsis Aerocom presents a compelling financial profile with strong profitability metrics, including high EBITDA margins and exceptional return ratios (RONW and ROCE). The valuation, at a P/E of 13.8x, appears reasonable given these strengths. However, investors should also consider the inherent risks of SME IPOs, potential sector-specific challenges in aerospace and defence, and the premium valuation relative to NAV. A thorough assessment of these factors is crucial. Investors should consult a SEBI-registered financial advisor before making investment decisions.
What is Apsis Aerocom IPO GMP today?
Grey Market Premium (GMP) is an unofficial indicator of demand for an IPO, reflecting the price at which IPO shares are traded in the unofficial market before listing. For Apsis Aerocom IPO, if GMP is available, it might suggest market sentiment. However, GMP is speculative and can fluctuate rapidly. It should not be the sole basis for investment decisions, as it is not regulated and can be misleading.
How to apply for Apsis Aerocom IPO?
You can apply for the Apsis Aerocom IPO through your stockbroker's trading platform using the ASBA (Application Supported by Blocked Amount) facility. This can be done via net banking or through the broker's mobile app. Your funds will remain blocked in your bank account until the allotment of shares. The application process is straightforward and can be completed online.
Disclaimer: This review is informational analysis based on publicly available data. It is NOT investment advice. The verdict is a data-driven signal, not a recommendation to buy or sell. IPO GMP is unofficial and unregulated. Consult a SEBI-registered financial advisor before making investment decisions. Stock market investments are subject to market risks.